Generating Pharmaceutical Sales before Marketing Authorization


When a patient has a serious illness and there is no approved drug available, the physician may want to try one which has not been authorized for marketing by national health authorities but has shown promise in clinical trials. European Named Patient Programs, like US compassionate use programs, offer physicians access to pharmaceuticals which have not yet been licensed. However, there is one important difference: in Europe an unlicensed drug can be reimbursed. This presents drug-makers with an opportunity to generate revenues while development is still in-progress.

Significant Revenues Are Possible

The additional revenues can be considerable. For example, Pharmion, a US based company focusing on Oncology and Hematology reported dramatic increases in its Thalidomide sales from $1.9 million in 2Q '03 to $15.3 million in 2Q '04, primarily due to named patient sales in Europe for Multiple Myeloma. Thalidomide sales accounted for approximately 75% of Pharmion's total revenues for the first half of 2004, according to company sources, and were generated while the product awaits marketing approval for this indication. Before receiving European Marketing Approval, Shire's Argylin® for essential thrombocythaemia generated about 5% of its total sales from its European named patient program.

Though thalidomide and Agrylin were licensed in the USA for some indications, pharmaceutical companies do set-up named patient programs and receive full reimbursement for drugs that are not licensed for any indication in any market. Examples include: Insmed's SomatoKine® authorized for named patient use for Primary Lateral Sclerosis, Growth Hormone Insensitivity Syndrome (GHIS) and Severe Insulin Resistance and Protherics' ViperaTAb? authorized for named patient use for adder snake bites.

Other Benefits of Named Patient Programs

A named patient program can speed uptake after official launch. Physicians, who have had experience before launch, via clinical trials or named patient programs, often become early adopters and references for other physicians once the drug is freely circulating.

Named patient programs, like US compassionate use programs, can increase good-will toward the company because they simplify the process of gaining access for patients in critical need. Smaller companies often can not afford the administrative time and costs of shipping drugs around the world before launch. This can lead to frustration and resentment towards a company that many physicians will remember long after a drug is officially on the market. Creating a formal channel eliminates the unfortunate need of denying requests and risking ill-will later.

A named patient program should be considered an important part of a pre-launch program. It increases awareness to a pharmaceutical's existence, creates excitement, generates good-will and speeds penetration of the product after launch.

Frequent Communication is Necessary

If one of the objectives is to generate revenues, setting up a named patient program is just the beginning. In order to achieve success, physicians need to be aware of the product and what they need to do to get it. Typical methods of informing physicians, such as sales rep visits and ads, may not be appropriate because a license is necessary to market a drug. While physicians are used to simply writing a prescription and being done with it, named patient programs require paper-work that some find tedious. Therefore the company needs to create an appropriate communication plan and work closely with the targeted medical community to keep them informed and simplify the process.

Issues to Consider

You have decided to make a named patient program part of your pre-marketing plan, what now?

? Administration: Do you "go it alone" or work with a company that is experienced at administering named patient programs?

There are several experienced organizations that can assist your company by gaining approval, setting-up the program, doing administration and taking care of physical distribution. If your organization is well resourced and has a pipe-line of products that will require named patient programs, it might be worthwhile acquiring the expertise internally. However, if you have few appropriate products or a stream-lined organization, it is probably best to consider outsourcing.

? Communication: You've set up the program, how do you optimize it?

If you do not have an experienced European marketing group, an organization that is familiar in sales and marketing of pharmaceuticals in Europe can help you to maximize participation in the named patient program. A communication plan, if properly developed and implemented can increase product awareness, but communication concerning an unlicensed product must be done appropriately. This plan should ensure that your entire target group:

? Is fully aware of the product AND the program

? Knows what needs to be done to take advantage of the program

? Has an advocate available to guide them through the process

The Author, Dr Gene Emmer, is President of Med Services Europe B.V., a European-based consultancy focused on Sales, Marketing and Business Development of Pharmaceutical, Diagnostic and Medical Products. http://www.MedServicesEurope.com +31648566707







Related News



Obama to broaden role of genetics in medical care - Atlanta Journal Constitution

Obama to broaden role of genetics in medical care
Atlanta Journal Constitution,  USA -9 hours ago
Now the pursuit of “personalized medicine” is expected to get a major push from the incoming administration of President-elect Barack Obama. ...

Strong medicine - Financial Times

Telegraph.co.uk

Strong medicine
Financial Times, UK -5 hours ago
The European Commission is right to criticise drugmakers' practice of extending their monopolies on high cost medicines by keeping out low-cost generic ...
Drug firms 'block' cheap medicineBBC News
EU report: Drug makers block market entry of competing medicinesXinhua
EU says drug industry delay tactics cost us €3bnTimes Online
United Press International - euronews
all 337 news articles

Media Bombardment Is Linked To Ill Effects During Childhood - Washington Post

3 News NZ

Media Bombardment Is Linked To Ill Effects During Childhood
Washington Post, United States -2 hours ago
"Our kids are sponges, and we really need to remember they learn from their environment," said coauthor Cary P. Gross, professor at Yale School of Medicine. ...
Screen addiction 'bad for kids' health'Melbourne Herald Sun
all 14 news articles

Effort in Senegal to Join Traditional & Conventional Medicine - Voice of America

Voice of America

Effort in Senegal to Join Traditional & Conventional Medicine
Voice of America -14 hours ago
By Scott Bobb Traditional medicine was once thought of as sorcery or quackery. But the craft is slowly gaining the respect of conventional medical ...
Modern West African Market Offers Traditional Remedies for IllnessVoice of America
all 2 news articles

Pediatricians and the Promotion and Support of Breastfeeding - Archives of Pediatrics

Pediatricians and the Promotion and Support of Breastfeeding
Archives of Pediatrics -10 hours ago
Author Affiliations: Division of Adolescent Medicine, Department of Pediatrics, Cooper University Hospital, University of Medicine and Dentistry of New ...
Adult medicine enters the medical homeAAP News (subscription)
all 2 news articles

Cardiologists Debate Expensive Heart Scans - New York Times

Cardiologists Debate Expensive Heart Scans
New York Times, United States -4 hours ago
In the latest study, published last week in The New England Journal of Medicine, researchers assessed the accuracy of CT angiography in identifying ...
Heading off heart attacks in womenChicago Daily Herald
all 4 news articles


Organogenesis Receives Two Prestigious Awards for Economic Impact ... - MarketWatch

Organogenesis Receives Two Prestigious Awards for Economic Impact ...
MarketWatch -13 hours ago
Organogenesis was the first company to successfully mass produce living regenerative medicine products -- reaching hundreds of thousands of patients in the ...

Three FAAPs elected to Institute of Medicine - AAP News (subscription)

Three FAAPs elected to Institute of Medicine
AAP News (subscription) -13 hours ago
Three AAP Fellows were among 65 new members elected to the Institute of Medicine, one of the highest honors in the fields of health and medicine that ...
FELLOWS IN THE NEWSAAP News (subscription)
Lake Tahoe hosts Practical Pediatrics, offers range of seminarsAAP News (subscription)
all 3 news articles

New Marketing Coaching and Consulting Firm for Physicians ... - MarketWatch

New Marketing Coaching and Consulting Firm for Physicians ...
MarketWatch -15 hours ago
"There are a growing number of physicians making the switch to concierge medicine, but they either don't know how to effectively convert their existing ...

China Medicine Corporation Awarded GSP Certification - MarketWatch

China Medicine Corporation Awarded GSP Certification
MarketWatch -16 hours ago
("China Medicine" or "the Company"), a leading developer and distributor of prescription and over the counter pharmaceuticals, traditional Chinese medicines...